Revenio Group Oyj (CHIX:REG1VH) Market Cap: €356.7 Mil (As of Jul. 02, 2026)


CHIX:REG1VH Revenio Group Oyj CHIX:REG1VH
77 GF Score
Price €16.47
GF Value €40.41
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Market Cap?

Revenio Group Oyj CHIX:REG1VH 77 Market Cap is €356.7 Mil as of Jul. 02, 2026. GuruFocus rates CHIX:REG1VH with a GF Score™ of 77/100 and a GF Value™ of €40.41. The stock has 2 warning signs investors should review. Among 869 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 66.28% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Revenio Group Oyj's share price for the quarter that ended in Mar. 2026 was €22.8. Revenio Group Oyj's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 26.6 Mil. Therefore, Revenio Group Oyj's market cap for the quarter that ended in Mar. 2026 was €606.6 Mil.

Revenio Group Oyj's quarterly market cap declined from Sep. 2025 (€730.9 Mil) to Dec. 2025 (€606.5 Mil) but then increased from Dec. 2025 (€606.5 Mil) to Mar. 2026 (€606.6 Mil).

Revenio Group Oyj's annual market cap increased from Dec. 2023 (€587.2 Mil) to Dec. 2024 (€939.4 Mil) but then declined from Dec. 2024 (€939.4 Mil) to Dec. 2025 (€606.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Revenio Group Oyj's Enterprise Value for Today is €340.1 Mil.


Revenio Group Oyj  (CHIX:REG1Vh) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Revenio Group Oyj Market Cap Related Terms


Revenio Group Oyj Market Cap Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj Market Cap Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,482.22 1,129.65 587.17 939.41 606.55

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 939.48 737.57 730.92 606.55 606.59

CHIX:REG1VH vs ABT, SYK, MDT: Market Cap Comparison

For the Medical Devices subindustry, Revenio Group Oyj's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Market Cap distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's Market Cap falls into.


CHIX:REG1VH
77GF Score
Revenio Group Oyj CHIX:REG1VH
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Revenio Group Oyj's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€22.8*26.603
=€606.5

Revenio Group Oyj's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€22.8*26.605
=€606.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €356.7 Mil mean?
Revenio Group Oyj (CHIX:REG1VH) has a Market Cap of €356.7 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Revenio Group Oyj and its competitors. According to the industry distribution chart, Revenio Group Oyj ranks #293 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 33.7%.
Is Revenio Group Oyj's Market Cap too high?
Revenio Group Oyj's current Market Cap is €356.7 Mil. Based on the distribution chart, Revenio Group Oyj ranks #293 out of 869 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Revenio Group Oyj has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #293 out of 869 companies for Market Cap. This puts Revenio Group Oyj in the upper half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current Market Cap is €356.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (CHIX:REG1VH) has a current Market Cap of €356.7 Mil. The stock's GF Value™ is €40.41, compared to a current price of €16.47 — trading 59.2% below its estimated fair value. The current Market Cap is €356.7 Mil. Revenio Group Oyj's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current Market Cap is €356.7 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €16.47 is trading 59.2% below its estimated GF Value™ of €40.41.

Key valuation signals for CHIX:REG1VH:

  • Market Cap: €356.7 Mil
  • GF Value™: €40.41 vs. price of €16.47 (59.2% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
77GF Score

Get the complete analysis for CHIX:REG1VH

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.47
Price
€40.41
GF Value